ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 206.893K |
Day Range | - - - |
52 Wk Range | 1.110 - 3.290 |
Market Cap | $159.455M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.45% |
Days to Cover | 1.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
There are no as such competitors for ProQR Therapeutics.
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Thursday, April 18, 2024. The analyst firm set a price target for 2.00 expecting PRQR to rise to within 12 months (a possible 2.04% upside). 12 analyst firms have reported ratings in the last year.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.96 last updated April 25, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ProQR Therapeutics.
ProQR Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for ProQR Therapeutics.
ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.